Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study
- 1 January 2001
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 16 (1) , 193-195
- https://doi.org/10.1093/ndt/16.1.193
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologistNephrology Dialysis Transplantation, 1999
- Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactionsBritish Journal of Clinical Pharmacology, 1998
- Interferon Therapy for Chronic Hepatitis C in Hemodialysis Patients: Increased Serum Levels of InterferonNephron, 1998